XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.13

-0.5%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (9541)	4/6/1999 10:31:00 PM
From: Cacaito	Read Replies (3) of 17367

Bpi against Chlamydiae could "possibly" add faster killing abilities and control of inflammation. One week or one month treatment instead of 3 months to a year. The regular antibiotics killing could become a double sword, kill and trigger inflammation. Bpi seems the obvious strategic missile vs the low tech kaboom antibiotics. Caveat: All of the above 99% pure speculation, 0.01% fact.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next